九州通品牌怎么样 申请店铺

我要投票 九州通在减肥药行业中的票数:462 更新时间:2025-04-25
九州通是哪个国家的品牌?「九州通」是 九州通医药集团股份有限公司 旗下著名品牌。该品牌发源于湖北,由创始人刘宝林在2000期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力九州通品牌出海!通过在本页面挂载九州通品牌的产品链接和联系方式,可以提高九州通产品曝光!跨境电商爆单神器,目前只要100元/年哦~

九州通怎么样

九州通医药集团股份有限公司是一家以药品、医疗器械、生物制品、保健品等产品批发、零售连锁、药品生产与研发及有关增值服务为核心业务的大型企业集团。

截至2012年12月31日,九州通医药集团拥有总资产148.04亿元,员工9,148人,下属公司80余家,直营和加盟的零售连锁药店875家。2012年,九州通医药集团实现营业收入295.08亿元,上缴税收近5亿元。

九州通医药集团拥有完善的品种结构和丰富的客户资源,经营品规达160,000多个,上游供货商5,600家,下游客户70,000多家,取得了国内131种药品的全国或区域总经销或总代理资格。至今为止,九州通医药集团已在全国22个省会城市设立了22家省级子公司(大型医药物流中心)、在29个地级市设立了29家地级公司(地区医药物流配送中心)及400多个终端配送点,形成了覆盖全国大部分县级行政区域的物流配送网络。

打造企业核心竞争力,九州通医药集团秉持“技术让服务更卓越”的理念,致力于现代物流技术和信息技术的开发和应用。目前,九州通医药集团是国内唯一具备独立整合物流规划、物流实施、系统集成能力的医药分销企业,并取得了20多项自主知识产权,在现代物流技术和信息技术方面处于国内领先、国际一流的地位,是国内医药行业唯一获得“中国物流改革开放30年旗帜企业”称号的企业。

九州通医药集团具备向上下游客户提供需求解决方案及增值服务的能力,并逐渐将技术增值服务延伸到了上下游产业链,形成了独具特色的物流管理、供应链管理、医院管理三大产品线,可以满足客户对技术的最高要求。

近年来,九州通医药集团曾获得“国家5A级物流企业”、“湖北省最具影响力民营企业”、“湖北省守合同重信用企业”、“中国社会责任感优秀企业”、“全国非公有制企业双强百佳党组织”等多项荣誉。

未来,九州通医药集团将顺应医药市场变革,继续坚持以医药分销为核心业务,以医院纯销、中药材、医疗器械、零售连锁为战略业务,以物流技术营销、电子商务、国际贸易、原料药等为新兴业务的业务组合战略;扩大和完善医药营销网络布局,不断为医药健康产业提供高性价比服务,努力将九州通打造成为中国医药健康产业最佳服务商。

JIUZHOUTONG Pharmaceutical Group Co., Ltd. is a large-scale enterprise group with the core business of wholesale, retail chain, drug production and R & D and related value-added services of drugs, medical devices, biological products, health products and other products. As of December 31, 2012, JIUZHOUTONG Pharmaceutical Group has a total assets of 14.804 billion yuan, 9148 employees, more than 80 subordinate companies, 875 retail chain drugstores directly operated and joined. In 2012, JIUZHOUTONG Pharmaceutical Group achieved an operating revenue of 29.508 billion yuan and turned in tax revenue of nearly 500 million yuan. JIUZHOUTONG Pharmaceutical Group has a complete variety structure and rich customer resources. It operates more than 160000 products, 5600 upstream suppliers and 70000 downstream customers. It has obtained the qualification of national or regional general distribution or general agent of 131 kinds of drugs in China. So far, JIUZHOUTONG Pharmaceutical Group has set up 22 provincial subsidiaries (large pharmaceutical logistics centers) in 22 provincial capitals, 29 prefecture level companies (regional pharmaceutical logistics distribution centers) and more than 400 terminal distribution points in 29 prefecture level cities, forming a logistics distribution network covering most county-level administrative regions of the country. To build the core competitiveness of the enterprise, JIUZHOUTONG Pharmaceutical Group adheres to the concept of "technology makes service more excellent", and is committed to the development and application of modern logistics technology and information technology. At present, JIUZHOUTONG Pharmaceutical Group is the only pharmaceutical distribution enterprise in China that has the ability to independently integrate logistics planning, logistics implementation and system integration, and has obtained more than 20 independent intellectual property rights. It is in the leading position in modern logistics technology and information technology in China and the first-class position in the world. It is the only one in the domestic pharmaceutical industry that has won the title of "30 years banner enterprise of China's logistics reform and opening up" Enterprises. JIUZHOUTONG Pharmaceutical Group has the ability to provide demand solutions and value-added services to upstream and downstream customers, and gradually extends technology value-added services to the upstream and downstream industrial chains, forming a unique logistics management, supply chain management, hospital management three product lines, which can meet the highest requirements of customers for technology. In recent years, JIUZHOUTONG Pharmaceutical Group has won many honors, such as "national 5A level logistics enterprise", "the most influential private enterprise in Hubei Province", "Hubei Province contract abiding and trustworthy enterprise", "China's outstanding enterprise of social responsibility", "national top 100 Party organizations of non-public enterprises". In the future, JIUZHOUTONG Pharmaceutical Group will continue to adhere to the core business of pharmaceutical distribution, the strategic business of hospital pure sales, Chinese herbal medicine, medical devices, retail chain, the business combination strategy of logistics technology marketing, e-commerce, international trade, API and other emerging businesses, expand and improve the layout of pharmaceutical marketing network, and continue to serve the medical health The industry provides cost-effective services and strives to build Jiuzhoutong into the best service provider in China's pharmaceutical and health industry.

本文链接: https://brand.waitui.com/02808d9a5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中银资产在深圳成立科创私募基金,出资额50亿

36氪获悉,天眼查App显示,近日,深圳中鑫鹏翔科创私募股权投资基金合伙企业(有限合伙)成立,执行事务合伙人为中银资本私募基金管理(北京)有限公司,出资额50亿人民币,经营范围包括以私募基金从事股权投资、投资管理、资产管理等活动。合伙人信息显示,该基金由中银金融资产投资有限公司、中银资本私募基金管理(北京)有限公司共同出资。

2小时前

A股三大指数午间休盘集体上涨,地产股爆发

36氪获悉,A股三大指数午间休盘集体上涨,沪指涨0.15%,深成指涨0.87%,创业板指涨1.07%;石油化工、房地产、通信设备板块领涨,南国置业、世联行涨停,博创科技涨超6%,新凤鸣涨超4%;医药、煤炭、银行板块跌幅居前,立方制药跌停,恒源煤电跌超5%,上海银行跌超2%。

2小时前

加速海外仓网建设,阿里国际站加码“海外现货”招商

36氪获悉,在登顶美国App购物榜之后,B2B跨境电商平台阿里国际站进一步开启“海外现货”招商,招募在美国和欧洲有现货的外贸商家。阿里国际站将帮助这批新加入的“海外现货商家”,一键直连海外社媒上的KOL、达人店铺及MCN直播机构,并上线分销工具方便商家快速提高订单转化,加速生意增长。目前阿里国际站“海外现货模式”面向美国和欧洲27国市场,针对在当地有海外仓、或者商品备货在第三方海外仓的跨境商家开放,产品类目以标准品为主。

2小时前

半日主力资金加仓电子股,抛售银行股

主力资金早间净流入电子、计算机、通信等板块,净流出银行、医药生物、石油石化等板块。具体到个股来看,拓维信息、东方财富、我爱我家获净流入18.79亿元、7.69亿元、7.09亿元。净流出方面,农业银行、贝因美、拉卡拉遭抛售4.32亿元、3.09亿元、2.98亿元。(第一财经)

2小时前

转转集团与中国资源循环集团电子电器公司签署战略合作协议

36氪获悉,中国资源循环集团粤港澳大湾区展业推进会于深圳市举办,会上,中国资源循环集团电子电器公司揭牌成立,与转转集团等循环经济头部企业达成战略合作并签署合作协议。双方将建立全面的战略合作伙伴关系,充分发挥各自优势,拟在手机高质量回收等各个领域开展框架合作,共同推动中国废旧电子电器设备回收领域的高质量发展。

2小时前

本页详细列出关于九州通的品牌信息,含品牌所属公司介绍,九州通所处行业的品牌地位及优势。
咨询